Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.

Article  CAS  PubMed  Google Scholar 

Turner R. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.

Article  Google Scholar 

Song MY, Steinhubl SR, Topol EJ. The beginning of the end of fingersticks? The Lancet. 2018;392:203.

Article  Google Scholar 

Lameijer A, Fokkert MJ, Edens MA, Gans ROB, Bilo HJG, Van Dijk PR. Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6). BMJ Open Diabetes Res Care. 2021;9(1):e002124.

Fokkert M, Van Dijk P, Edens M, Barents E, Mollema J, Slingerland R, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care. 2019;7(1):e000809.

Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64:2609–52.

Article  PubMed  PubMed Central  Google Scholar 

Emamipour S, van Dijk PR, Bilo HJG, Edens MA, van der Galiën O, Postma MJ, et al. Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring (isCGM) Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9). J Diabetes Sci Technol. 2024;18(1):135–42.

Article  CAS  PubMed  Google Scholar 

Jiao Y, Lin R, Hua X, Churilov L, Gaca MJ, James S, et al. A systematic review: COST-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022;5(6): e369.

Article  PubMed  PubMed Central  Google Scholar 

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;2015:350.

Google Scholar 

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:148–60.

Article  PubMed  PubMed Central  Google Scholar 

PROSPERO. Available at: https://www.crd.york.ac.uk/prospero/#searchadvanced. Accessed 18 Oct 2022.

de Jong LA, Li X, Emamipour S, van der Werf S, Postma MJ, van Dijk PR, et al. Model and empirical data-based cost-utility studies of continuous glucose monitoring in individuals with type 1 diabetes: a protocol of a systematic review on methodology and quality. Pharmacoecon Open. 2023;7(6):1007–13.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372.

Google Scholar 

Reddy N, Verma N, Dungan K. Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic Control. Endotext. 2020; South Dartmouth (MA): MDText.com, Inc.; 2000.

Girardin CM, Huot C, Gonthier M, Delvin E. Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. Clin Biochem. 2009;42:136–42.

Article  CAS  PubMed  Google Scholar 

Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol. 2020;58:401–10.

Article  PubMed  Google Scholar 

Bramer WM, Giustini D, De Jong GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc. 2016;104:240–3.

Article  PubMed  PubMed Central  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.

Husereau D, Drummond M, Augustovski F, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Explanation and Elaboration: A report of the ISPOR CHEERS II Good Practices Task Force. Value in Health. 2022;25:10–31.

Article  PubMed  Google Scholar 

Wijnen B, Van Mastrigt G, Redekop W, Majoie H, De Kinderen R, Evers SMAA. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16:723–32.

Article  PubMed  Google Scholar 

Philips Z, Bojke L, Sculpher M, Claxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics. 2006;24:355–71.

Article  PubMed  Google Scholar 

Odnoletkova I. Cost-effectiveness of therapeutic education to prevent the development and progression of type 2 diabetes: systematic review. J Diabetes Metab. 2014;5:9

Evers S, Goossens M, de Vet H, van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria - PubMed. Int J Technol Assess Health Care. 2005;21:240–5.

Article  PubMed  Google Scholar 

Vemer P, Corro Ramos I, van Voorn GAK, Al MJ, Feenstra TL. AdViSHE: a validation-assessment tool of health-economic models for decision makers and model users. Pharmacoeconomics. 2016;34:349.

Article  CAS  PubMed  Google Scholar 

OECD. Purchasing power parities (PPP). 2024. Available at: https://data.oecd.org/conversion/purchasing-power-parities-ppp.htm#indicator-chart. Accessed 29 Jan 2024.

OECD. Exchange rates. 2024. Available at: https://data.oecd.org/conversion/exchange-rates.htm#indicator-chart. Accessed 29 Jan 2024.

Turner HC, Lauer JA, Tran BX, Teerawattananon Y, Jit M. Adjusting for inflation and currency changes within health economic studies. Value Health. 2019;22:1026–32.

Article  PubMed  Google Scholar 

Huang ES, O’Grady M, Basu A, Winn A, John P, Lee J, et al. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care. 2010;33:1269–74.

Article  PubMed  PubMed Central  Google Scholar 

Emamipour S, Pagano E, Di Cuonzo D, Konings SRA, van der Heijden AA, Elders P, et al. The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model. Acta Diabetol. 2022;59:949–57.

Article  PubMed  PubMed Central  Google Scholar 

Rotondi MA, Wong O, Riddell M, Perkins B. population-level impact and cost-effectiveness of continuous glucose monitoring and intermittently scanned continuous glucose monitoring technologies for adults with type 1 diabetes in Canada: a modeling study. Diabetes Care. 2022;45:2012–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao X, Ming J, Qu S, Li HJ, Wu J, Ji L, et al. Cost-effectiveness of flash glucose monitoring for the management of patients with type 1 and patients with type 2 diabetes in China. Diabetes Ther. 2021;12:3079–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McQueen RB, Ellis SL, Campbell JD, Nair K V., Sullivan PW. Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes. Cost Eff Resour Alloc. 2011;9:13.

Lambadiari V, Ozdemir Saltik AZ, De Portu S, Buompensiere MI, Kountouri A, Korakas E, et al. Cost-effectiveness analysis of an advanced hybrid closed-loop insulin delivery system in people with type 1 diabetes in Greece. Diabetes Technol Ther. 2022;24:316–23.

Article  CAS  PubMed  Google Scholar 

Conget I, Martín-Vaquero P, Roze S, Elías I, Pineda C, Álvarez M, et al. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinol Diabetes Nutr. 2018;65:380–6.

Article  Google Scholar 

Jendle J, Smith-Palmer J, Delbaere A, de Portu S, Papo N, Valentine W, et al. Cost-effectiveness analysis of sensor-augmented insulin pump therapy with automated insulin suspension versus standard insulin pump therapy in patients with type 1 diabetes in Sweden. Diabetes Ther. 2017;8:1015–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riemsma R, Ramos IC, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, et al. Integrated sensor-augmented pump therapy systems [the MiniMed® ParadigmTM Veo system and the VibeTM and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation. Health Technol Assess. 2016;20:1–252.

Article  PubMed Central  Google Scholar 

Quality Health Ontario. Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment. Ontario; 2018.

Isitt JJ, Roze S. Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia: response to letter from Hellmund, Richard and Welsh, Zoe. Diabet Med. 2022;39(7):e14831.

Ly TT, Brnabic AJM, Eggleston A, Kolivos A, McBride ME, Schrover R, et al. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes. Value Health. 2014;17:561–9.

Article  PubMed  Google Scholar 

Roze S, Saunders R, Brandt AS, de Portu S, Papo NL, Jendle J. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes. Diabet Med. 2015;32:618–26.

Article  CAS  PubMed